<DOC>
	<DOC>NCT02980068</DOC>
	<brief_summary>This is an open-label, single-center study to examine distinguishing features of the structure and function of the oral and gut microbiome in healthy adult normal volunteers compared to volunteers with PH-HFpEF in the breakdown of oral nitrate.</brief_summary>
	<brief_title>A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<criteria>Undergoing clinical right heart catheterization or RHC in the past 6 months. PHHFpEF group: PH secondary to heart failure with preserved ejection fraction (PHHFpEF) hemodynamically defined by a mean PAP â‰¥ 25 mm Hg, a PCWP &gt; 15 mm Hg, and have a PVR &gt; 3 Woods units and normal cardiac index Control group: Normal hemodynamics on clinical right heart catheterization within the prior 6 months Use of systemic antibiotics, chlorhexidine mouthwash, or immunesuppression (oral prednisone, chemotherapy, etc.) within the previous three months Current pregnancy or lactation Uncontrolled systemic hypertension based on repeated measurement of sitting systolic blood pressure &gt;185 mm Hg or sitting diastolic blood pressure &gt;110 mm Hg at screening History of portal hypertension or chronic liver disease, including hepatitis B and/or hepatitis C (with evidence of recent infection and/or active virus replication) defined as mild to severe hepatic impairment (ChildPugh Class BC) Has chronic renal insufficiency as defined by serum creatinine &gt;2.5 mg/dL at screening or requires dialytic support Known history of left ventricular ejection fraction &lt; 45% by multiple gated acquisition scan (MUGA), angiography, or echocardiography History of atrial septostomy Repaired or unrepaired congenital heart disease Pericardial constriction Restrictive or congestive cardiomyopathy Symptomatic coronary disease with demonstrable ischemia Recent addition or change in dosing of hormonal contraception medications (OCP, IUD, DepoProvera)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>